Skip to main content
. 2022 Jun;22(2):362–368. doi: 10.4314/ahs.v22i2.41

Table 2.

Changes of serum calcium, phosphorus, calcium phosphorus product, and iPTH of patients at baseline and 4, 8, and 12 weeks of lanthanum carbonate treatment (500 mg/d)

Baseline 4 weeks 8 weeks 12 weeks
Serum calcium
(2.10–2.55mmol/L)
2.15±0.18 2.14±0.13 2.06±0.16 2.05±0.05
Serum phosphorus
(0.9–1.6mmol/L)
2.49±0.51 2.29±0.46* 1.87±0.36** 1.65±0.34**
Calcium phosphorus
product (23.44–50.59mg2/dL2)
69.40±17.34 60.67±14.84* 50.40±8.91** 44.27±9.67**
iPTH (12–88pg/ml) 185.58±109.48 184.83±118.23 174.84±123.66 164.73±96.20
*

P<0.05

**

P<0.01 vs. baseline. n=38